MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

Cebrián, Carolina, Zucca, Fabio A., Mauri, Pierluigi, Steinbeck, Julius A., Studer, Lorenz, Scherzer, Clemens R., Kanter, Ellen, Budhu, Sadna +5 more·2014·Nature Communications

Cited by (337)

Items 201–300 of 337

  1. Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease
    Mingshu Mo, Wei Yuan Huang, Congcong Sun, Limin Zhang, Luan Cen, Yousheng Xiao, Guo-Fei Li, Xinling Yang, Shaogang Qu, Pingyi Xu · 2016 · Chinese Medical Journal
  2. A Re-Appraisal of Pathogenic Mechanisms Bridging Wet and Dry Age-Related Macular Degeneration Leads to Reconsider a Role for Phytochemicals
    Roberto Pinelli, Francesca Biagioni, Fiona Limanaqi, Miorica Bertelli, Elena Scaffidi, Maico Polzella, Carla Letizia Busceti, Francesco Fornai · 2020 · International Journal of Molecular Sciences
  3. T-cell based immunotherapies for Parkinson’s disease
    Rodrigo Pacheco · 2021 · Exploration of Neuroprotective Therapy
  4. The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease
    Yan Shen, Xingfang Guo, Chao Han, Fang Jung Wan, Kai Ma, Shiyi Guo, Luxi Wang, Yun Fei Xia, Ling Liu, Zhicheng Lin et al. · 2017 · Cellular and Molecular Life Sciences
  5. Alpha‐synuclein triggers T‐cell response. Is Parkinson's disease an autoimmune disorder?
    Sara Bandrés‐Ciga, Mark R. Cookson · 2017 · Movement Disorders
  6. Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration
    Michael R. Strickland, Emily J. Koller, Doris Z. Deng, Carolina Ceballos‐Diaz, Todd Eliot Golde, Paramita Chakrabarty · 2017 · Neurobiology of Disease
  7. MHC class I in dopaminergic neurons suppresses relapse to reward seeking
    Gen Murakami, Mitsuhiro Edamura, Tomonori Furukawa, Hideya Kawasaki, Isao Kosugi, Atsuo Fukuda, Toshihide Iwashita, Daiichiro Nakahara · 2018 · Science Advances
  8. Peripheral–central immune interactions in Parkinson’s disease: insights into innate and adaptive immunity
    Jarika Jahan Tumpa, Qurat Ul Ain Hayder, Nowshin Sharmily Maisa, Md. Nazmul Islam · 2025 · Frontiers in Molecular Neuroscience
  9. Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson’s disease and examination of its possible etiologies: infectious or autoimmune?
    Oriol de Fàbregues, María Clara Sellés, David Ramos-Vicente, Gerard Roch, Miquel Vila, Jordi Bové · 2023 · Neurobiology of Disease
  10. Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology
    Fatema Currim, Reeya Tanwar, Josephine M. Brown-Leung, Neha Paranjape, Jennifer Liu, Laurie H. Sanders, Jonathan A. Doorn, Jason R. Cannon · 2024 · NeuroToxicology
  11. Narcolepsy Type I as an autoimmune disorder
    Birgitte Rahbek Kornum · 2021 · Handbook of clinical neurology
  12. The major histocompatibility complex participates in Parkinson’s disease
    Rou Gu, Jianyu Pan, Maher Un Nisa Awan, Xiaowei Sun, Yan Fang, Liping Bai, Jie Bai · 2024 · Pharmacological Research
  13. Principles of mitochondrial vesicle transport
    Gian‐Luca McLelland, Edward A. Fon · 2018 · Current Opinion in Physiology
  14. Anti-GAD epileptic encephalopathy in a toddler with Parry-Romberg syndrome
    Stefano Sotgiu, Alessandro Consolaro, Susanna Casellato, Francesc Graus, Paolo P Picco · 2019 · Neurological Sciences
  15. Overexpression of astroglial major histocompatibility complex class I in the medial prefrontal cortex impairs visual discrimination learning in mice
    Bolati Wulaer, Kazuhiro Hada, Akira Sobue, Norimichi Itoh, Toshitaka Nabeshima, Taku Nagai, Kiyofumi Yamada · 2020 · Molecular Brain
  16. Glutamatergic receptor dysfunction in spinal cord contributes to the exaggerated exercise pressor reflex in heart failure
    Hanjun Wang, Rebecca E. Cahoon, Edgar B. Cahoon, Hong Zheng, Kaushik P. Patel, Irving H. Zucker · 2014 · American Journal of Physiology-Heart and Circulatory Physiology
  17. Expression and alternative splicing of classical and nonclassical MHCI genes in the hippocampus and neuromuscular junction
    Mazell M. Tetruashvily, John W. Melson, Joseph J. Park, Xiaoyu Peng, Lisa M. Boulanger · 2016 · Molecular and Cellular Neuroscience
  18. A bibenzyl compound 20C protects rats against 6-OHDA-induced damage by regulating adaptive immunity associated molecules
    Shuo Wang, Qi-wen Han, Tian-Tian Zhou, Chenglu Zhang, Chenggen Zhu, Zhou Xin, Nai‐Hong Chen, Yu‐He Yuan, Jian‐Gong Shi · 2020 · International Immunopharmacology
  19. Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
    Sara Almeida Ferreira, Conghui Li, Ida Hyllen Klæstrup, Zagorka Vitic, Rikke Kongsgaard Rasmussen, Asger Kirkegaard, Gitte U. Toft, Cristine Betzer, Pia Svendsen, Poul Henning Jensen et al. · 2023 · npj Parkinson s Disease
  20. Alterations of Peripheral Lymphocyte Subsets in Isolated Rapid Eye Movement Sleep Behavior Disorder
    Yuanchu Zheng, Yatong Li, Huihui Cai, Wenyi Kou, Yang Chen, Siming Li, Jiawei Wang, Ning Zhang, Tao Feng · 2024 · Movement Disorders
  21. The mechanisms of white matter injury and immune system crosstalk in promoting the progression of Parkinson’s disease: a narrative review
    Wen Ma, Yifan Geng, Youhan Liu, Huixin Pan, Qinglu Wang, Yaohua Zhang, Liping Wang · 2024 · Frontiers in Aging Neuroscience
  22. Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond
    Océane Perdaens, Vincent Van Pesch · 2024 · International Journal of Molecular Sciences
  23. Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo
    Mingshu Mo, Gui-Hua Li, Congcong Sun, Shuxuan Huang, Lei Wei, Limin Zhang, Miaomiao Zhou, Zhuohua Wu, Wenyuan Guo, Xinling Yang et al. · 2018 · Translational Neurodegeneration
  24. Tapasin assembly surveillance by the RNF185/Membralin ubiquitin ligase complex regulates MHC-I surface expression
    Michael L. van de Weijer, Krishna Samanta, Nikita Sergejevs, Lu-Lin Jiang, María Emilia Dueñas, Tiaan D. J. Heunis, Timothy Y. Huang, Randal J. Kaufman, Matthias Trost, Sumana Sanyal et al. · 2024 · Nature Communications
  25. WDR43 is a potential diagnostic biomarker and therapeutic target for osteoarthritis complicated with Parkinson’s disease
    Hongquan Heng, Jie Liu, Mingwei Hu, Dazhuang Li, Wenxing Su, Jian Li · 2022 · Frontiers in Cellular Neuroscience
  26. Mitochondrial Antigen Presentation: A Vacuolar Path to Autoimmunity in Parkinson's Disease
    Pascale Baden, Michela Deleidi · 2016 · Trends in Immunology
  27. Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson’s Disease
    Zhigang Jiao, Wenlong Zhang, Chaojun Chen, Xiaoqin Zhu, Xiang Chen, Miaomiao Zhou, Guoyou Peng, Hanqun Liu, Jiewen Qiu, Yuwan Lin et al. · 2018 · ACS Chemical Neuroscience
  28. Indoleamine 2,3-dioxygenase (IDO1) – Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson’s Disease?
    Milene Gonçalves, Paulo Rodrigues‐Santos, Cristina Januário, Marco Cosentino, Frederico Costa Pereira · 2024 · International Immunopharmacology
  29. The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity
    Daniel Torrente, Enming Joseph Su, Alí Francisco Citalán‐Madrid, Gerald P. Schielke, Daniel Magaoay, Mark Warnock, Tamara K. Stevenson, Kris M. Mann, Flavie Lesept, Nathalie Delétage et al. · 2025 · Journal of Neuroinflammation
  30. Pathways to Progressive Disability in Multiple Sclerosis: The Role of Glial Cells in Chronic CNS Inflammation
    Volker Siffrin · 2025 · Glia
  31. Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
    Jaimin Patel, Nikhil Panicker, Valina Lynn Dawson, Ted M. Dawson · 2022 · CNS Drugs
  32. Autoimmune Limbic Encephalitis in Patients with Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Bu Yeon Heo, Myung-Won Lee, Suyoung Choi, Yunju Jung, Thi Thuy Duong Pham, Yunseon Jang, Jung‐Hyun Park, Sora Kang, Jeong Suk Koh, Deog‐Yeon Jo et al. · 2023 · Cells
  33. Neuronal-enriched small extracellular vesicles trigger a PD-L1-mediated broad suppression of T cells in Parkinson’s disease
    Zhichun Chen, Wenming Li, Bo Meng, Chongchong Xu, Yiqi Huang, Guanglu Li, Zhexing Wen, Jun Liu, Zixu Mao · 2024 · iScience
  34. Novel insights into the ROCK-JAK-STAT signaling pathway in upper respiratory tract infections and neurodegenerative diseases
    Jiaxuan Li, Naihui Mao, Ying Wang, Shuli Deng, Keda Chen · 2024 · Molecular Therapy
  35. PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection
    Sherilyn Junelle Recinto, Alexandra Kazanova, Lin Liu, Brendan Cordeiro, Shobina Premachandran, Hicham Bessaiah, Alexis Allot, Elia Afanasiev, Sriparna Mukherjee, Jessica Pei et al. · 2025 · npj Parkinson s Disease
  36. Duzhong Fang Attenuates the POMC-Derived Neuroinflammation in Parkinsonian Mice
    Lili Li, Shanshan Fan, Wenqi Zhang, Dongna Li, Zhen Yu Yang, Pengwei Zhuang, Juan Han, Hong Guo, Yanjun Zhang · 2021 · Journal of Inflammation Research
  37. Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target
    R. S. Mitra, Lavienraj Premraj, Tien Kheng Khoo · 2023 · Parkinsonism & Related Disorders
  38. Disease mechanisms as subtypes: Inflammation in Parkinson disease and related disorders
    David G. Standaert, Ashley S. Harms, Gabrielle M. Childers, Jhodi M. Webster · 2023 · Handbook of clinical neurology
  39. Transcriptional Response to Tick-Borne Flavivirus Infection in Neurons, Astrocytes and Microglia In Vivo and In Vitro
    Ebba Rosendal, Richard Lindqvist, Nunya Chotiwan, Johan Henriksson, Anna K. Överby · 2024 · Viruses
  40. Microglia cause structural remodeling of noradrenergic axon in the trigeminal spinal subnucleus caudalis after infraorbital nerve injury in rats
    Yoshinori Hayashi, Jo Otsuji, Eri Oshima, Suzuro Hitomi, Junjun Ni, Kentaro Urata, Ikuko Shibuta, Koichi Iwata, Masamichi Shinoda · 2023 · Brain Behavior & Immunity - Health
  41. Changes in Neuroimmunological Synapses During Cerebral Ischemia
    Lynn Bitar, Berta Puig, Thomas G. Oertner, Ádám Dénes, Tim Ullrich Magnus · 2024 · Translational Stroke Research
  42. Infection triggers symptoms similar to those of Parkinson’s disease in mice lacking PINK1 protein
    Mary K. Herrick, Malú G. Tansey · 2019 · Nature
  43. Immunological aspects of Parkinson's disease
    O. V. Belova, Tatiana I. Arefieva, Svetlana N. Moskvina · 2020 · S S Korsakov Journal of Neurology and Psychiatry
  44. MhcII Regulates Transmission of α-Synuclein-Seeded Pathology in Mice
    Elsa Gonzalez De La Cruz, Quan Vo, Katie Moon, Karen N. McFarland, Mary J. Weinrich, Tristan Williams, Benoit I. Giasson, Paramita Chakrabarty · 2022 · International Journal of Molecular Sciences
  45. The Mitochondrial Connection in Parkinson's Disease
    Eric A. Schon, Diana Matheoud, Serge Przedborski · 2025 · Cold Spring Harbor Perspectives in Medicine
  46. Ursolic acid derivative UAOS-Na treats experimental autoimmune encephalomyelitis by immunoregulation and protecting myelin
    Maolin Wang, Chenming Gu, Yifu Yang, Liang Chen, Kaixian Chen, Jun Bao Du, Huali Wu, Yiming Li · 2023 · Frontiers in Neurology
  47. Dysregulated Coagulation in Parkinson’s Disease
    X. Wang, Wenxin Li, Xinyue Zhao, Ning Hu, Xi Wang, Xilin Xiao, Kai Yang, Taolei Sun · 2024 · Cells
  48. Hidden face of Parkinson’s disease: Is it a new autoimmune disease?
    Min Gi Jo, Seon‐Hee Kim, Seung Pil Yun · 2024 · Neural Regeneration Research
  49. Prevention of Parkinson’s Disease: From Risk Factors to Early Interventions
    Ming Guan Ng, Brendan Jun Lam Chan, Rhun Yian Koh, Khuen Yen Ng, Soi Moi Chye · 2023 · CNS & Neurological Disorders - Drug Targets
  50. Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic Neurons
    Casimir de Rham, Zuleika Calderin Sollet, Pierre R. Burkhard, Jean Villard · 2020 · Stem Cells and Development
  51. Spatial RNA sequencing identifies robust markers of vulnerable and resistant human midbrain dopamine neurons and their expression in Parkinson’s Disease
    Julio Aguila Benitez, Shangli Cheng, Nigel Kee, Ming Cao, Menghan Wang, Qiaolin Deng, Eva Hedlund · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Neurological Complications in Inborn Errors of Immunity: A Scoping Review of Clinical Spectrum, Pathophysiological Mechanisms, and Therapeutic Strategies
    Ningkun Xiao, Xin‐Lin Huang, Linzi Chen, Wanli Zang, Maosen Guan, Tianjiao Li, Ирина Александровна Тузанкина, В. А. Черешнев, Guojun Liu · 2025 · Clinical Reviews in Allergy & Immunology
  53. Revisiting the alpha-synuclein paradox in melanoma-Parkinson’s disease connection: more than a tale of two cell fates
    Jacopo Aiello, Roberta Zamarato, Claudia Moscheni, Cristiana Perrotta, Mario Clerici, Daria Trabattoni, Mara Biasin, Fiona Limanaqi · 2025 · Cellular and Molecular Life Sciences
  54. iPSC ‐derived human cortical organoids display profound alterations of cellular homeostasis following SARS ‐ CoV ‐2 infection and Spike protein exposure
    Gioia Cappelletti, Lorenzo Brambilla, Sergio Strizzi, Fiona Limanaqi, Valentina Melzi, Mafalda Rizzuti, Monica Nizzardo, Irma Saulle, Daria Trabattoni, Stefania Paola Corti et al. · 2025 · The FASEB Journal
  55. A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse Model
    Fabrice Faure, Lidia Yshii, Toufic Renno, Isabelle Coste, Bastien Joubert, Virginie Desestret, Roland Liblau, Jérôme Honnorat · 2023 · The Cerebellum
  56. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV- α -synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease
    Filip Fredlund, Itzia Jiménez-Ferrer, Kathleen Grabert, Lautaro F. Belfiori-Carrasco, Kelvin C. Luk, Maria Swanberg · 2024 · Journal of Parkinson s Disease
  57. The humoral immune landscape in Parkinson's disease: Unraveling antibody and B cell changes
    Zahra Baridjavadi, Mahmoud Mahmoudi, Narges Abdollahi, Negar Ebadpour, Samaneh Mollazadeh, Dariush Haghmorad, Seyed‐Alireza Esmaeili · 2024 · Cell Biochemistry and Function
  58. Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
    Carolina Cebrián, David L. Sulzer · 2017 · Elsevier eBooks
  59. Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein
    Upasana Ganguly, Sukhpal Singh, Sasanka Chakrabarti, Adesh Kumar Saini, Reena Vohra Saini · 2022 · Advances in protein chemistry and structural biology
  60. Mitochondrial antigen-specific CD8⁺ T cells drive dopamine neuron neurodegeneration
    Moustafa Nouh Elemeery, Alex Tchung, Salix Boulet, Nicolas Giguère, Sarah Mezrag, Jean‐François Daudelin, Amandine Even, Abigail Ralph, Sriparna Mukherjee, Claudie Beaulieu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Adaptive Immunity and Parkinson's Disease
    Wassim Elyaman · 2025 · Cold Spring Harbor Perspectives in Medicine
  62. Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson’s disease
    Alysia Ross, Natalie A. Prowse, Hui Zhang, Shawn P. Hayley, Sun Hongyu · 2025 · Frontiers in Cellular Neuroscience
  63. Co-signaling Molecules in Neurological Diseases
    Pia Kivisäkk, Samia Joseph Khoury · 2019 · Advances in experimental medicine and biology
  64. Curative Anti‐Inflammatory Properties of Chinese Optimized Yinxieling Formula in Models of Parkinson’s Disease
    Renrong Wei, Ouyang Jing, Weixian Lin, Tongxiang Lin · 2018 · Evidence-based Complementary and Alternative Medicine
  65. Identification of immune signatures in Parkinson’s disease based on co-expression networks
    Xiaolin Dong, Yanping Li, Qingyun Li, Wenhao Li, Gang Wu · 2023 · Frontiers in Genetics
  66. Alpha-synuclein supports interferon stimulated gene expression in neurons
    Aaron R. Massey, Brendan Monogue, Yixi Chen, Kelsey E. Lesteberg, Michaela E. Johnson, Liza Bergkvist, Jennifer A. Steiner, Jiyan Ma, Ravi Mahalingam, B.K. Kleinschmidt-Demasters et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Protein glycoxidation in neuropsychiatric disorders—from basic research to clinical practice
    Wiktor Orlof, Mateusz Maciejczyk · 2026 · Redox Biology
  68. The vicious cycle: unraveling the interplay between α-synuclein, mitochondrial dysfunction, and neuroinflammation in Parkinson’s disease
    Yu-lin Liang, Feng-ge Yang, Qiang Tang · 2026 · Journal of Neurology
  69. Identification of Parkinson’s disease-associated chromatin regulators
    Hailong Xing, Shanshan Wang, Ke Li · 2023 · Scientific Reports
  70. LncRNAs down-regulate Myh1, Casr, and Mis18a expression in the Substantia Nigra of aged male rats
    Guoliang Zhang, Yunxiao Kang, Xu Feng, Rui Cui, Qiqing Guo, Xiaoming Ji, Yuanxiang Huang, Yannan Ma, Shufeng Liu, Geming Shi · 2019 · Aging
  71. Killing ageing neurons, one cell at a time
    Jessica Wagner, Jonas J. Neher · 2021 · Nature Neuroscience
  72. Major histocompatibility complex expression in a rotenone model of Parkinson’s disease in rats
    Masami Ishido, Eiko Shimaya · 2016 · Fundamental Toxicological Sciences
  73. Risk Factor and Long-Term Outcome Analyses for Acute Limbic Encephalitis and Calcineurin Inhibitor-Induced Encephalopathy in Adults following Allogeneic Hematopoietic Cell Transplantation
    Nao Tanizawa, Hideo Koh, Hiroshi Okamura, Keiichi Yamamoto, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Shiro Koh, Satoru Nanno, Mitsutaka Nishimoto et al. · 2021 · Transplantation and Cellular Therapy
  74. LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration
    Carmela Giachino, Cataldo Tirolo, Salvatore Caniglia, Maria Francesca Serapide, Francesca L’Episcopo, Federico Bertoli, Claudio Giuliano, Marika Mearelli, Meike Jakobi, Nicole Schneiderhan‐Marra et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Evidence for Dopamine Abnormalities Following Acute Methamphetamine Exposure Assessed by Neuromelanin-Sensitive Magnetic Resonance Imaging
    Fei Tang, Hui Liu, Xiao Jie Zhang, Hui Zheng, Yong Ming Dai, Li Yun Zheng, Wen Han Yang, Yan Yao Du, Jun Liu · 2022 · Frontiers in Aging Neuroscience
  76. Immunity in Parkinson's disease - the role of adaptive and auto-immune responses and gut-microbiome axis
    Aditi S Iyengar, Peter Robert Dunkley, Phillip W. Dickson · 2025 · Journal of Neuroimmunology
  77. The immunoproteasome as a neuroimmune hub in the central nervous system: from proteostasis stress to inflammatory pathology
    Huiying Zhao, Yuexian Liu, Xingyong Chen · 2026 · Journal of Neuroinflammation
  78. Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson’s disease
    Alex Tchung, Amandine Even, Louis‐Éric Trudeau · 2026 · Trends in Neurosciences
  79. Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy
    Jae‐Seung Moon, Salvinaz Islam Moutusy, Mengrui Zhang, Alain Ndayisaba, Diego Rodriguez, Daniel N. El Kodsi, Anastasia Kuzkina, Shady Younis, Shaghayegh Jahanbani, Laura S. van Dam et al. · 2026 · Proceedings of the National Academy of Sciences
  80. Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies
    Qin-qin Wang, Qing-qing Sun, Yong-shun Guo, Shu Yin, Jiawei Zhou · 2026 · Translational Neurodegeneration
  81. Genome Editing of Pluripotent Stem Cells for Adoptive and Regenerative Cell Therapies
    Robert A. Blassberg · 2022 · GEN Biotechnology
  82. Neuroinflammation and Immune Dysfunction in the Mechanisms of Development of Parkinson’s Disease
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Neuroscience and Behavioral Physiology
  83. A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes
    Shuxia Wen, Yajun Li, Wanqing Xiang, Fei Shen, Nan Jiang, Duan Ma, Jin Zhang · 2025 · Neurobiology of Disease
  84. Multimodal relationships and multifactorial associations between oral microecological and neurodegenerative diseases
    Yi Zhou, Jiaxuan Li, Di Wang, Ling Peng, Keda Chen · 2025 · Neuropharmacology
  85. What Kaplan-Meier survival curves don't tell us about CNS disease
    Katelyn D. Miller, Glenn F. Rall · 2017 · Journal of Neuroimmunology
  86. Toothed Whales Have Black Neurons in the Blue Spot
    Simona Sacchini, Antonio Fernández, Blanca Mompeó, Raquel Ramírez‐Moreno, Manuel Arbelo, Unn Holgersen, Óscar Quesada‐Canales, Ayoze Castro-Alonso, M. Andrada · 2022 · Veterinary Sciences
  87. Neuroinflammation in Age-Related Neurodegenerative Diseases
    Kathryn P. MacPherson, Maria Elizabeth de Sousa Rodrigues, Amarallys F. Cintron, Malú G. Tansey · 2018 · Elsevier eBooks
  88. Properties of human central nervous system neurons in a glia-depleted (isolated) culture system
    Soo Yuen Leong, Andrew Kaplan, Lichun Wang, Guillermina Almazán, Alyson E. Fournier, Jack Perry Antel · 2015 · Journal of Neuroscience Methods
  89. LRRK2 regulates the activation of the unfolded protein response and antigen presentation in macrophages during inflammation
    Ahmed M. Fahmy, Tyler Cannon, Camberly Hernandez, Ali Ahmadi, Yong Zhong Xu, Benoit Barrette, Maha Ibrahim, Joël Lanoix, Guillermo Arango Duque, Erwin Schurr et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Patient‐Derived Neurons Exhibit α‐Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein–Associated Neurodegeneration
    Leonie M. Heger, Leonie Kertess, Clara Kaufhold, Francesco Gubinelli, Aida Cardona‐Alberich, Gamze Özata, Stephan A. Müller, Sarah K. Tschirner, Oliver Stehling, Martina Schifferer et al. · 2025 · Movement Disorders
  91. Parkinson's disease: A chronic systemic inflammatory disorder
    Hina Khan, Matthew J. Benskey · 2025 · Handbook of behavioral neuroscience
  92. Helicobacter pylori infection and α-synuclein pathology drive parallel neurodegenerative pathways in the substantia nigra
    Alejandro Soto-Avellaneda, Alice Prigent, Lindsay K. Meyerdirk, Noah Schautz, John Andrew Pospisilik, Lena Brundin, Michael X. Henderson · 2025 · Journal of Neuroinflammation
  93. The role of Th17 cells in the pathogenesis of Parkinson's disease: From immune dysregulation to neurodegeneration
    Jinyue Zhao, Huazheng Liang, Yong Bi · 2026 · Brain Research Bulletin
  94. The Clinical Utility of the Autoimmune Target Test for Neurologic Disease
    Soo-Hyun Kim, La‐He Jearn, Think‐You Kim · 2017 · Laboratory Medicine Online
  95. NEUROINFLAMMATION AND IMMUNE DYSFUNCTION IN THE PATHOGENESIS OF PARKINSON’S DISEASE
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Журнал высшей нервной деятельности им И П Павлова
  96. Immune response during idiopathic Parkinson's disease: From humans to animal models
    Sara Konstantin Nissen, Sara Almeida Ferreira, Ida Hyllen Klæstrup, Marina Romero‐Ramos · 2021 · International review of movement disorders
  97. Роль Т-клеточных субпопуляций в патогенезе и терапии болезни Паркинсона (обзор литературы)
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Сибирский вестник психиатрии и наркологии
  98. Tissue Plasminogen Activator Interaction with NMDAR1 Promotes Dopaminergic Neuron Degeneration in a Model of Α-Synuclein-Mediated Neurotoxicity
    Daniel Torrente, Enming Joseph Su, Gerald P. Schielke, Mark Warnock, Tamara K. Stevenson, Kris M. Mann, Denis Vivien, Daniel A. Lawrence · 2022 · SSRN Electronic Journal
  99. Neuron-derived exosomes trigger a PD-L1-mediated broad suppression of T cells in Parkinson’s disease
    Zhichun Chen, Chongchong Xu, Guanglu Li, Zhexing Wen, Jun Liu, Zixu Mao · 2022 · Research Square
  100. Uncovering immune characteristics of neurons in the context of multiple sclerosis and experimental autoimmune encephalomyelitis
    Abdulshakour Mohammadnia, Sienna Drake, Stéphanie Zandee, David Gosselin, Jack Perry Antel, Alexandre Prat, Alyson E. Fournier · 2024 · bioRxiv (Cold Spring Harbor Laboratory)